Nykode Therapeutics AS (NYKD.OL)
NOK 2.59
(15.42%)
NOK 2.59
(15.42%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | -0.12 USD | 12.68% |
| 2022 | -1.42 USD | -407.14% |
| 2021 | -0.28 USD | -105.56% |
| 2020 | 5.04 USD | 5807.81% |
| 2019 | -0.09 USD | 61.61% |
| 2018 | -0.23 NOK | -109.09% |
| 2017 | -0.11 NOK | -92.98% |
| 2016 | -0.06 NOK | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q2 | -0.02 USD | 61.11% |
| 2024 Q1 | -0.48 USD | -170.0% |
| 2023 FY | - USD | 12.68% |
| 2023 Q2 | -0.33 USD | 8.33% |
| 2023 Q3 | -0.36 USD | -9.09% |
| 2023 Q4 | -0.18 USD | 50.0% |
| 2023 Q1 | -0.36 USD | 14.29% |
| 2022 Q2 | -0.28 NOK | -33.33% |
| 2022 FY | - USD | -407.14% |
| 2022 Q4 | -0.42 USD | 17.65% |
| 2022 Q3 | -0.51 NOK | -82.14% |
| 2022 Q1 | -0.21 NOK | -165.63% |
| 2021 Q4 | 0.32 NOK | 239.13% |
| 2021 FY | - USD | -105.56% |
| 2021 Q3 | -0.23 NOK | 0.0% |
| 2020 FY | - USD | 5807.81% |
| 2019 FY | - USD | 61.61% |
| 2018 FY | - NOK | -109.09% |
| 2017 FY | - NOK | -92.98% |
| 2016 FY | - NOK | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| Arctic Bioscience AS | -1.79 NOK | 93.296% |
| Aqua Bio Technology ASA | -0.99 NOK | 87.879% |
| ArcticZymes Technologies ASA | 0.38 NOK | 131.579% |
| BerGenBio ASA | -13.30 NOK | 99.098% |
| Hofseth BioCare ASA | -0.27 NOK | 55.556% |
| PCI Biotech Holding ASA | -0.54 NOK | 77.778% |
| Thor Medical ASA | -0.03 NOK | -277.358% |
| Ultimovacs ASA | -5.50 NOK | 97.818% |